Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.21
-0.23 (-4.23%)
Apr 20, 2026, 12:33 PM EDT - Market open
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $281.78 million as of April 20, 2026. Its market cap has increased by 78.64% in one year.
Market Cap
281.78M
Enterprise Value
99.69M
1-Year Change
78.64%
Ranking
Category
Stock Price
$5.21
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $281.78M, an increase of 62.73%. That is a compound annual growth rate of 8.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 294.22M | 3.01% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 312.25M |
| Inhibikase Therapeutics | 311.87M |
| Foghorn Therapeutics | 310.52M |
| Artiva Biotherapeutics | 310.19M |
| Coherus Oncology | 305.35M |
| Eledon Pharmaceuticals | 302.35M |
| AC Immune | 298.60M |
| Minerva Neurosciences | 295.06M |